Nuplazid 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FX8A1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,458
Award facts
- Contract value 100% obligated
- $3,457.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. The contract calls for delivery of Nuplazid 10 mg tablets (30-count packages) with a firm fixed-price ceiling value of $3,457.87. This delivery order was issued without a set-aside designation and carries an ultimate completion date of October 16, 2025. DMS Pharmaceutical Group will perform the work at its Park Ridge location and leverage its established pharmaceutical distribution capabilities to fulfill this requirement.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables for military health facilities. DMS Pharmaceutical Group's track record with the DLA demonstrates consistent success in supplying specialized pharmaceutical products, positioning the company as a key vendor in the federal pharmaceutical supply chain for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FX8A1?
SPE2DB25FX8A1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FX8A1 worth?
The government has obligated $3,458 on SPE2DB25FX8A1.
Is contract SPE2DB25FX8A1 an order under another contract?
Yes. SPE2DB25FX8A1 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX8A1 competed?
The extent of competition for SPE2DB25FX8A1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award